⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XERS News
Xeris Biopharma Holdings, Inc. Common Stock
Periodic Paralysis Association Marks World Periodic Paralysis Day on March 23, Urging Faster Diagnosis and First-Ever Dedicated Research Funding
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Biopharma Subsidiaries File Recorlev ® Patent Infringement Lawsuit
businesswire.com
XERS
Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026
businesswire.com
XERS
Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026
businesswire.com
XERS
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
businesswire.com
XERS
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
businesswire.com
XERS
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
XERS
XERS